These findings identify CDC20 as a potential biomarker for SAC inhibitor sensitivity. Analysis of 1,700 human cancer cell lines combined with a CRISPR-Cas9 screen under MPS1 inhibition conditions ...
CRISPR-Cas9 is one of the biggest discoveries of the 21st century. Since it was developed in 2012, this gene-editing tool has revolutionized biology research, making it easier to study disease and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback